AAAAAA

   
Results: 1-7 |
Results: 7
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: A randomized phase II trial in small-cell lung cancer patients
Authors: Woll, PJ Thatcher, N Lomax, L Hodgetts, J Lee, SM Burt, PA Stout, R Simms, T Davies, R Pettengell, R
Citation: Pj. Woll et al., Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: A randomized phase II trial in small-cell lung cancer patients, J CL ONCOL, 19(3), 2001, pp. 712-719
Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel
Authors: Szlosarek, PW Lofts, FJ Pettengell, R Carter, P Young, M Harmer, C
Citation: Pw. Szlosarek et al., Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel, ANTI-CANC D, 11(4), 2000, pp. 275-278
Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines
Authors: Scott-Taylor, TH Pettengell, R Clarke, I Stuhler, G La Barthe, MC Walden, P Dalgleish, AG
Citation: Th. Scott-taylor et al., Human tumour and dendritic cell hybrids generated by electrofusion: potential for cancer vaccines, BBA-MOL BAS, 1500(3), 2000, pp. 265-279
A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response
Authors: Foran, JM Gupta, RK Cunningham, D Popescu, RA Goldstone, AH Sweetenham, JW Pettengell, R Johnson, PWM Bessell, E Hancock, B Summers, K Hughes, J Rohatiner, AZS Lister, TA
Citation: Jm. Foran et al., A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response, BR J HAEM, 109(1), 2000, pp. 81-88
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
Authors: Kottaridis, PD Milligan, DW Chopra, R Chakraverty, RK Chakrabarti, S Robinson, S Peggs, K Verfuerth, S Pettengell, R Marsh, JCW Schey, S Mahendra, P Morgan, GJ Hale, G Waldmann, H de Elvira, MCR Williams, CD Devereux, S Linch, DC Goldstone, AH Mackinnon, S
Citation: Pd. Kottaridis et al., In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation, BLOOD, 96(7), 2000, pp. 2419-2425
Characteristics and growth patterns of human peritoneal mesothelial cells:Comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources
Authors: Zhang, XY Pettengell, R Nasiri, N Kalia, V Dalgleish, AG Barton, DPJ
Citation: Xy. Zhang et al., Characteristics and growth patterns of human peritoneal mesothelial cells:Comparison between advanced epithelial ovarian cancer and non-ovarian cancer sources, J SOC GYN I, 6(6), 1999, pp. 333-340
B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis
Authors: Cliff, S Pettengell, R Gharge, S Marsden, RA
Citation: S. Cliff et al., B-cell lymphoma developing in a patient on cyclosporin for recalcitrant psoriasis, BR J DERM, 140(4), 1999, pp. 763-765
Risultati: 1-7 |